ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Clears Rapid Test For Aspergillus Infection

May 30, 2003

In Brief: Clinton Backs Ban On Human Cloning; Wisconsin Selects Niederhuber As Director

June 13, 1997

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

U.S. Radiologists Criticize Canadian Study Of Mammography Screening Showing No Benefit

November 27, 1992

Obey Again – Now He’s Blasting NCI For Not Helping NIOSH

September 17, 1976

Upton Closer To Decision On Control, Centers Merger; ACCC Defeats Motion In Opposition

March 16, 1979